A systematic review of cost-effectiveness analyses of novel agents in the treatment of multiple myeloma

Autor: Maarten R. Seefat, Kaz Groen, Stijn Dirven, David G. J. Cucchi, Sonja Zweegman, Hedwig M. Blommestein

Publikováno v: Seefat, M R, Cucchi, D G J, Dirven, S, Groen, K, Zweegman, S & Blommestein, H M 2021, ' A systematic review of cost-effectiveness analyses of novel agents in the treatment of multiple myeloma ', Cancers, vol. 13, no. 22, 5606 . https://doi.org/10.3390/cancers13225606
Cancers
Cancers, Vol 13, Iss 5606, p 5606 (2021)

Simple Summary New treatments in multiple myeloma are embraced by patients and physicians but are also associated with substantial higher costs. To ensure the affordability and accessibility of health care, an evaluation of the outcomes in relation t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782186a31cc67188979d1e742be0f2cb
https://research.vumc.nl/en/publications/e2ff5a82-f768-4a33-82fd-ce2181da2950